These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 29081088)

  • 1. Potential Immunotherapeutics for Immunosuppression in Sepsis.
    Shin J; Jin M
    Biomol Ther (Seoul); 2017 Nov; 25(6):569-577. PubMed ID: 29081088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sepsis-induced immune dysfunction: can immune therapies reduce mortality?
    Delano MJ; Ward PA
    J Clin Invest; 2016 Jan; 126(1):23-31. PubMed ID: 26727230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression.
    Patil NK; Bohannon JK; Sherwood ER
    Pharmacol Res; 2016 Sep; 111():688-702. PubMed ID: 27468649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immune system's role in sepsis progression, resolution, and long-term outcome.
    Delano MJ; Ward PA
    Immunol Rev; 2016 Nov; 274(1):330-353. PubMed ID: 27782333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the Study of Immunosuppressive Mechanisms in Sepsis.
    Fu X; Liu Z; Wang Y
    J Inflamm Res; 2023; 16():3967-3981. PubMed ID: 37706064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sepsis and Nosocomial Infection: Patient Characteristics, Mechanisms, and Modulation.
    Denstaedt SJ; Singer BH; Standiford TJ
    Front Immunol; 2018; 9():2446. PubMed ID: 30459764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sepsis-Induced Immunosuppression in Neonates.
    Hibbert JE; Currie A; Strunk T
    Front Pediatr; 2018; 6():357. PubMed ID: 30555806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in Immune Monitoring Approaches for Sepsis-Induced Immunosuppression.
    Yao RQ; Ren C; Zheng LY; Xia ZF; Yao YM
    Front Immunol; 2022; 13():891024. PubMed ID: 35619710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advances in immunotherapeutic research of sepsis].
    Dong L; Lyu J; Ding L; Liu Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Feb; 29(2):184-187. PubMed ID: 28625271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alleviation of exhaustion-induced immunosuppression and sepsis by immune checkpoint blockers sequentially administered with antibiotics-analysis of a new mathematical model.
    Gillis A; Beil M; Halevi-Tobias K; van Heerden PV; Sviri S; Agur Z
    Intensive Care Med Exp; 2019 Jun; 7(1):32. PubMed ID: 31187301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate Immunity in the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome and Its Implications for Therapy.
    Horiguchi H; Loftus TJ; Hawkins RB; Raymond SL; Stortz JA; Hollen MK; Weiss BP; Miller ES; Bihorac A; Larson SD; Mohr AM; Brakenridge SC; Tsujimoto H; Ueno H; Moore FA; Moldawer LL; Efron PA;
    Front Immunol; 2018; 9():595. PubMed ID: 29670613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of sepsis-induced immunosuppression and immunological modification therapies for sepsis.
    Ono S; Tsujimoto H; Hiraki S; Aosasa S
    Ann Gastroenterol Surg; 2018 Sep; 2(5):351-358. PubMed ID: 30238076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sepsis-Induced Immunosuppression.
    Torres LK; Pickkers P; van der Poll T
    Annu Rev Physiol; 2022 Feb; 84():157-181. PubMed ID: 34705481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. Time for a paradigm change?
    Leentjens J; Kox M; van der Hoeven JG; Netea MG; Pickkers P
    Am J Respir Crit Care Med; 2013 Jun; 187(12):1287-93. PubMed ID: 23590272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sepsis: pathophysiology and clinical management.
    Gotts JE; Matthay MA
    BMJ; 2016 May; 353():i1585. PubMed ID: 27217054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the Cellular Origin of the Mononuclear Phagocyte System Sheds Light on the Myeloid Postulate of Immune Paralysis in Sepsis.
    Poulin LF; Lasseaux C; Chamaillard M
    Front Immunol; 2018; 9():823. PubMed ID: 29740436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sepsis Care Pathway 2019.
    Labib A
    Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
    [No Abstract]   [Full Text] [Related]  

  • 18. [Reversing ICU-acquired immunosuppression: an innovative biomarker-guided therapeutic strategy for decreasing sepsis mortality and nosocomial infection rate].
    Monneret G; Lepape A; Venet F
    Pathol Biol (Paris); 2011 Dec; 59(6):329-33. PubMed ID: 21981928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoadjuvant therapy in sepsis: novel strategies for immunosuppressive sepsis coming down the pike.
    Watanabe E; Thampy LK; Hotchkiss RS
    Acute Med Surg; 2018 Oct; 5(4):309-315. PubMed ID: 30338075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precision Immunotherapy for Sepsis.
    Peters van Ton AM; Kox M; Abdo WF; Pickkers P
    Front Immunol; 2018; 9():1926. PubMed ID: 30233566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.